Silicon Valley Capital Partners’s Eli Lilly LLY Stock Holding History

Silicon Valley Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12M	Sell	13,009 -4,703	-27%	-$4.77M	1.17%	20
2025 Q4	$19M	Sell	17,712 -1,908	-10%	-$1.82M	1.73%	17
2025 Q3	$15M	Buy	19,620 +1,499	+8%	+$1.12M	1.41%	21
2025 Q2	$14.1M	Buy	18,121 +1,990	+12%	+$1.55M	1.47%	21
2025 Q1	$13.3M	Buy	16,131 +4,040	+33%	+$3.36M	1.73%	17
2024 Q4	$9.33M	Buy	12,091 +11,852	+4,959%	+$9.81M	1.04%	30
2024 Q3	$212K	Hold	239	–	–	0.03%	70
2024 Q2	$217K	Buy	239 +100	+72%	+$80K	0.03%	70
2024 Q1	$108K	Hold	139	–	–	0.02%	84
2023 Q4	$80.8K	Buy	139 +1	+0.7%	+$584	0.01%	87
2023 Q3	$74.3K	Hold	138	–	–	0.01%	89
2023 Q2	$64.7K	Buy	138 +66	+92%	+$27.7K	0.01%	93
2023 Q1	$24.7K	Buy	+72	New	+$24.3K	0.01%	125

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Silicon Valley Capital Partners's LLY Position: Q1 2026 in Review

Silicon Valley Capital Partners reduced its Eli Lilly (LLY) stake by 27% in Q1 2026, selling an estimated $4.77M and leaving 13,009 shares worth $12M. The position accounts for 1.17% of the portfolio, ranked #20.

Silicon Valley Capital Partners first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $19M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Silicon Valley Capital Partners held 13,009 shares of Eli Lilly worth $12M as of Q1 2026.
Silicon Valley Capital Partners sold 4,703 Eli Lilly shares in Q1 2026, an estimated $4.77M.
Eli Lilly made up 1.17% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #20 holding.
Silicon Valley Capital Partners first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
Silicon Valley Capital Partners's Eli Lilly position peaked at $19M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.